PMC:7461420 / 82821-83048 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T293","span":{"begin":142,"end":145},"obj":"Body_part"},{"id":"T294","span":{"begin":156,"end":159},"obj":"Body_part"}],"attributes":[{"id":"A293","pred":"fma_id","subj":"T293","obj":"http://purl.org/sig/ont/fma/fma67095"},{"id":"A294","pred":"fma_id","subj":"T294","obj":"http://purl.org/sig/ont/fma/fma67095"}],"text":"Nucleoside analogs with inhibition activity against SARS‐CoV‐2 RdRP (adenosine, guanosine, and sofosbuvir are included for comparison). RdRP, RNA‐dependent RNA polymerase; SARS‐CoV, severe acute respiratory syndrome coronavirus"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T388","span":{"begin":52,"end":56},"obj":"Disease"},{"id":"T389","span":{"begin":172,"end":176},"obj":"Disease"},{"id":"T390","span":{"begin":182,"end":215},"obj":"Disease"}],"attributes":[{"id":"A388","pred":"mondo_id","subj":"T388","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A389","pred":"mondo_id","subj":"T389","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A390","pred":"mondo_id","subj":"T390","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Nucleoside analogs with inhibition activity against SARS‐CoV‐2 RdRP (adenosine, guanosine, and sofosbuvir are included for comparison). RdRP, RNA‐dependent RNA polymerase; SARS‐CoV, severe acute respiratory syndrome coronavirus"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T963","span":{"begin":35,"end":43},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"Nucleoside analogs with inhibition activity against SARS‐CoV‐2 RdRP (adenosine, guanosine, and sofosbuvir are included for comparison). RdRP, RNA‐dependent RNA polymerase; SARS‐CoV, severe acute respiratory syndrome coronavirus"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T57667","span":{"begin":0,"end":10},"obj":"Chemical"},{"id":"T42555","span":{"begin":69,"end":78},"obj":"Chemical"},{"id":"T67983","span":{"begin":80,"end":89},"obj":"Chemical"},{"id":"T36809","span":{"begin":95,"end":105},"obj":"Chemical"}],"attributes":[{"id":"A53045","pred":"chebi_id","subj":"T57667","obj":"http://purl.obolibrary.org/obo/CHEBI_33838"},{"id":"A95901","pred":"chebi_id","subj":"T42555","obj":"http://purl.obolibrary.org/obo/CHEBI_16335"},{"id":"A55430","pred":"chebi_id","subj":"T67983","obj":"http://purl.obolibrary.org/obo/CHEBI_16750"},{"id":"A31843","pred":"chebi_id","subj":"T36809","obj":"http://purl.obolibrary.org/obo/CHEBI_85083"}],"text":"Nucleoside analogs with inhibition activity against SARS‐CoV‐2 RdRP (adenosine, guanosine, and sofosbuvir are included for comparison). RdRP, RNA‐dependent RNA polymerase; SARS‐CoV, severe acute respiratory syndrome coronavirus"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T83","span":{"begin":63,"end":67},"obj":"http://purl.obolibrary.org/obo/GO_0003968"},{"id":"T84","span":{"begin":136,"end":140},"obj":"http://purl.obolibrary.org/obo/GO_0003968"}],"text":"Nucleoside analogs with inhibition activity against SARS‐CoV‐2 RdRP (adenosine, guanosine, and sofosbuvir are included for comparison). RdRP, RNA‐dependent RNA polymerase; SARS‐CoV, severe acute respiratory syndrome coronavirus"}

{"project":"LitCovid-PubTator","denotations":[{"id":"2534","span":{"begin":136,"end":140},"obj":"Gene"},{"id":"2535","span":{"begin":63,"end":67},"obj":"Gene"},{"id":"2536","span":{"begin":52,"end":62},"obj":"Species"},{"id":"2537","span":{"begin":172,"end":180},"obj":"Species"},{"id":"2538","span":{"begin":0,"end":10},"obj":"Chemical"},{"id":"2539","span":{"begin":69,"end":78},"obj":"Chemical"},{"id":"2540","span":{"begin":80,"end":89},"obj":"Chemical"},{"id":"2541","span":{"begin":95,"end":105},"obj":"Chemical"}],"attributes":[{"id":"A2534","pred":"tao:has_database_id","subj":"2534","obj":"Gene:43740578"},{"id":"A2535","pred":"tao:has_database_id","subj":"2535","obj":"Gene:43740578"},{"id":"A2536","pred":"tao:has_database_id","subj":"2536","obj":"Tax:2697049"},{"id":"A2537","pred":"tao:has_database_id","subj":"2537","obj":"Tax:694009"},{"id":"A2538","pred":"tao:has_database_id","subj":"2538","obj":"MESH:D009705"},{"id":"A2539","pred":"tao:has_database_id","subj":"2539","obj":"MESH:D000241"},{"id":"A2540","pred":"tao:has_database_id","subj":"2540","obj":"MESH:D006151"},{"id":"A2541","pred":"tao:has_database_id","subj":"2541","obj":"MESH:D000069474"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Nucleoside analogs with inhibition activity against SARS‐CoV‐2 RdRP (adenosine, guanosine, and sofosbuvir are included for comparison). RdRP, RNA‐dependent RNA polymerase; SARS‐CoV, severe acute respiratory syndrome coronavirus"}